. home.aspx



Novartis blazes Big Pharma trail, striking deal with Canadian company to distribute medical marijuana products

March 19, 2018 / Eric Palmer

In what may be the first foray by Big Pharma into the sale of medical marijuana products, Novartis has struck a deal with a Canadian company that sells medical cannabis products not only in its home country but also in Europe. Nanaimo, British Columbia-based Tilray announced today that it has a binding agreement with Sandoz Canada to be its exclusive supplier of “non-smokable/non-combustible medical cannabis products.”